Replies to post #2203 on Spectrum Pharmaceutecals Inc (SPPI)

[Phoenix300]

Your responses are extremely helpful for a layman like myself. Do you envision that if the 50 patients results come within reason of matching the results from the first 11 patients that the company would ask the FDA to skip P3 with these stellar results. BTD
I have been told the current standard of care in non small cell lung cancer has a 8% response rate. And POZI’s was very high in the first 11 patients.

I would bet the FDA wanted a larger sample size to grant them skipping P3 BTD.

If they are granted BTD do you have a price target for the SPPI?